aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
lunes, 25 de mayo de 2026
How to solve the hidden bottleneck in lipid nanoparticle development
https://www.news-medical.net/industry-focus/How-to-solve-the-hidden-bottleneck-in-lipid-nanoparticle-development
Outdated offline methods are slowing you down. They compromise speed, consistency, and regulatory confidence. It’s time for a continuous solution.
This new eBook from Inprocess LSP shows how to overcome these bottlenecks with real-time, continuous particle size analysis. It offers practical guidance on enhancing process control, accelerating development, and achieving seamless scale-up.
Lipid nanoparticles (LNPs) are transforming drug delivery, powering innovations from mRNA vaccines to gene therapies. Yet, maintaining precise size control, which is essential for stability, efficacy, and regulatory approval, remains a major challenge. Traditional offline analysis often leads to delays, inconsistencies, and a lack of real-time visibility into production.
No hay comentarios:
Publicar un comentario